Skip to content

To study the characteristics of the pain arising due to mucormycosis

Prevalence, distribution and correlates of pain in patients with mucormycosis-A cross-sectional study. - (P.R.E.D.I.C.O.MUCOR)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036517
Enrollment
90
Registered
2021-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

None listed

Sponsors

Karnataka Institute of Medical Sciences Hubballi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mucormycosis confirmed/suspected patients admitted in our hospital for treatment with or without pain

Exclusion criteria

Exclusion criteria: Patients with age less than 18 years and more than 100 years

Design outcomes

Primary

MeasureTime frame
1.To estimate the prevalence (proportion) of pain in patients with mucormycosis.Timepoint: 1.To estimate the prevalence (proportion) of pain in patients with mucormycosis.

Secondary

MeasureTime frame
2. To study the type, regional distribution and characteristics of pain in patients with mucormycosis. 3. To study the determinants of pain including presence of pre-existing covid, diabetes, any surgical intervention done, extent of disease and relieving medications. Timepoint: After admission

Countries

India

Contacts

Public ContactMilon Vasant Mitragotri

Karnataka Institute Of Medical Sciences

milon.mitragotri4@gmail.com07406796763

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026